The aim of this study was to determine the correlation between lipophilicity and maximum residue limit (MRL) value specified for veterinary drugs in the fatty tissue of various animal species. The analysis was performed on a group of 73 compounds with different modes of action and MRL values determined for the fatty tissue of animals. Additionally, the logarithm of water/organic phase partition ratio (LogP) and the ratio of ionised and unionised substance in buffer with pH 7.4 (LogD7.4) were calculated. The main analysis was performed after the division of the whole group into six fractions. The linear correlation and regression analysis were used to determine the indirect relationship between the mean arithmetic value of LogP or LogD7.4 in selected fractions and related LogMRL of the drugs tested. The calculations revealed a linear correlation between fractioned lipophilicity and LogMRL values for the analysed compounds. The existence of indirect relationship between lipophilicity and MRL values determined for fatty tissue was confirmed.
Introduction
One of the basic topological parameters of a drug determining the substance distribution is its lipophilicity (1, 16) . It is usually expressed as a logarithm of water/organic phase partition ratio (LogP) or ratio of ionised and unionised substance in buffer with pH 7.4 (LogD7.4). It is necessary to know the LogP and LogD7. 4 values for all phases of the drug development process. In the case of animal tissues or other products which are intended for human consumption, the specificity of the drug usage is associated with the determination of the maximum residue limits (MRL) value. This procedure serves to protect human health and life by determining the safe dosage ranges and proper withdrawal time. Drug withdrawal time is different for different tissues. It results from the differences in tissue structure and a variable drug tissue-affinity. Fatty tissue plays a special role in the analysis of veterinary products residues. It is a poorly vascularised tissue to which drugs soluble in fats, i.e. lipophilic drugs, show a special affinity (18) . Numerous studies have shown that the correlation between the LogP value obtained by in silico methods and by a liquid-liquid shaking method is very high. At present, both methods are accepted (20, 21, 22) . Due to a naturally high affinity of lipophilic drugs to fatty tissue, they should also be deposited there in higher concentrations. That should be reflected by the MRL values determined for the drugs, whose presence in fatty tissue is monitored. Currently, no documents issued by Registration Agencies provide a sufficiently precise limit beyond which a drug should be considered as highly lipophilic in the sense of a possible risk of significant accumulation in fat. Some documents define an easilyaccumulated substance as a substance with octanol/water partition coefficient (LogP) >3, (6) . Other documents state the value of lipophilicity calculated using EPI Suite TM algorithm (LogKow) ≥3.5 as a critical value indicating strong lipophilicity of a drug (10) . In the context of environmental drug accumulation the limit (critical value) is LogKow ≥4, (9) . European Medicines Agency (EMA) defines the value of LogKow ≥4.5 as a critical one in the context of the phenomena of persistence, bioaccumulation, and the analysis of toxicity (7) . So far, it has not been determined how LogP influences veterinary drugs accumulation in fatty tissue in the aspect of MRL. The correlation between the value of LogP and the degree of drug accumulation in fatty tissue has not been studied either. However, MRL values for fatty tissue were set out for the large group of veterinary drugs. Therefore, the aim of the study was to estimate whether there is any relationship between LogP, LogD7.4 and the LogMRL value determined for drugs in the fatty tissue of various animal species and for various groups of drugs. Reference Laboratories exercise official control over veterinary drug residues in products of animal origin across the European Union. One of the problems that still remains unsolved is the procedure in case of detection of drugs used "off label" (extra label) in controlled products. Extra Label Drug Use (ELDU) is defined as the use of medications in an animal in the manner including changes to the indications, species, dosages, etc. (2) . In such cases the administered drug does not have a determined MRL value. Reckless ELDU in animal production may result in the presence of potentially harmful drug residues in edible tissues and food of animal origin (13) . Moreover, it may also contribute to development and dissemination of antimicrobial resistance (26) . This study attempts to create the model which could at least partially determine the risk when reference laboratories detect substances used in "extra label" way. Additionally, the presented model may be a useful tool for Veterinary Inspection or experts appointed to resolve the issue of the ELDU. The problem of "off label" (extra label) substances in treatment of food producing animals is growing (8) .
A model describing dependency between lipophilicity and MRL could prove useful in risk assessment.
Material and Methods
Analysed drugs and data calculations. Seventythree different, currently accepted MRL values for fatty tissue were used for calculations (5) . The data of the MRL values were obtained from the latest Commission Regulation of the European Union. Exclusion criteria of the analysed compounds were calculations of MRL using the sums of: pharmacologically active substance and metabolite or metabolites, hydrolysed residues, oxidised residues recalculated as active substance, etc. The data were included for analysis only when a parent drug or one marker was suggested (Table 1 ).
An analysis of lipophilicity of the examined drugs/metabolites was preceded by the transformation of a traditional record of a chemical structure into the simplified molecular input line entry system (SMILES) form. This form of record was used as a source data for calculations performed by ACD/ChemSketch v. 10 programme. SMILES code was used for the calculation of LogP values in LogKow and octanol/water partition coefficient based on ALOGPS algorithm (XLogP) variants (17 Model creation. Three fractions of LogD7.4 were selected in preliminary analysis (first -drugs with LogD7.4≤0; second -drugs with LogD7.4>0 and ≤6; third -drugs LogD7.4>6) (Fig. 1) .
Group division and the analysis of means within the groups is one of the data analysis methods in the case of which a level of dispersion resulting from high fluctuation of single values is very high. A similar model was also used in other studies (4, 11, 12, 19) . The main analysis was provided after splitting the whole group into six fractions. Considering the fact that the scale of lipophilicity expressed by LogP usually ranges from 0 to 7, LogP values used for the determination of the correlation with MRL were determined as partial analysis for six fractions (0, 1, 2, 3, 4, 5) of the analysed compounds as an arithmetic mean for each fraction. Fractions of LogP were determined for the following values: arithmetic mean for all compounds with LogP > 5 -fraction 5; arithmetic mean for all compounds with LogP > 4 -fraction 4, and then fractions 3, 2, 1, and 0 in analogous ranges. LogD7. 4 and MRL values used for the determination of the correlation were obtained in a similar manner for six fractions of analysed compounds, as an arithmetic mean for each fraction. To define the trend of dependency between selected fractions, linear regression was performed (3). The structure of the fractions was as follows: fraction 0 -LogP > 0 (n = 9), fraction 1 -LogP > 1 (n = 19), fraction 2 -LogP > 2 (n = 31), fraction 3 -LogP > 3 (n = 41), fraction 4 -LogP > 4 (n = 47), fraction 5 -LogP > 5 (n = 60). Table 1 . Octanol/water partition coefficients and related maximum residue limits (MRL) in fat tissue LogP  arithmetic mean of octanol/water partition coefficient; LogD7.4  arithmetic mean of octanol/buffer pH 7.4 partition coefficient; CLogD7.4 -octanol/buffer pH 7.4 partition coefficient (MarvinSketch algorithm); CLogP -octanol/water partition coefficient (MarvinSketch algorithm); XLogP -octanol/water partition coefficient (ALOGPS algorithm, PubMed); LogKow -octanol/water partition coefficient (EPI Suite TM algorithm) (16) were confirmed by the Fisher's test (confidence interval 95%) and differences of P < 0.05 were regarded as statistically significant. The coefficient of determination (R 2 ) of the observed versus predicted data was obtained. The leave-one-out (LOO) method was used for model cross-validation (14, 27) . Squared cross-validated correlation coefficient (Q 2 ) parameter and differences between Q 2 and R 2 were calculated as a measure of the internal performance and model predictive ability. Q 2 was calculated according to the formula:
where Yobs -observed value for the i-th object, Y -value of the i-th object estimated by using a model, Ym -average value of the validation set. Predictive residual sum of squares (PRESS) was calculated using the formula: (14, 15, 22, 23, 27) .
Results
The direct correlation between the LogP values and MRL values was very low. R 2 for LogP and MRL values was 0.0150 and R 2 value for LogD7.4 and MRL was as low as 0.0067. The preliminary analysis indicated a linear relationship only in the case of LogD7.4 and MRL in selected ranges (Fig. 1) Table 2 . Maximum residue limits (MRL) and octanol/water partition coefficients in six analysed fractions LogP  arithmetic mean of octanol/ water partition coefficient; LogD7.4  arithmetic mean of octanol/buffer pH 7.4 partition coefficient and related MRL in six fractions (≥0 to ≥5) of the analysed substances (n = 73) The arithmetic mean LogP value for the whole analysed group of drugs (n = 73) was 2.00 ± 3.56. The arithmetic mean LogP value for groups of lipophilic drugs (LogP≥0, n = 60) was 3.26 ± 2.04. The arithmetic mean LogP value for groups of hydrophilic drugs (LogP<0, n = 13) was -3.83 ± 3.29. The arithmetic mean LogD7.4 value for the whole analysed group of drugs (n = 73) was 0.23 ± 5.19. The arithmetic mean LogD7.4 value for groups of lipophilic drugs (LogD7.4>0, n = 45) was 3.11 ± 2.13. The arithmetic mean LogD7.4 value for groups of hydrophilic drugs (LogD7.4<0, n = 28) was -4.39 ± 5.31.
In the main analysis (the whole group divided into six fractions) for the linear fit, a correlation of statistical significance (P < 0.05) was demonstrated between the fractions LogP, LogD7.4 and MRL value in the analysed group of drugs (Fig. 2) . The dependence between LogP fractions and relating MRL values was found significant (F = 418.21; P < 0.05; These equations could be useful in calculation of approximate MRL value in the case "off label" drug identification in routine control of fat from foodproducing animals.
Discussion
As in the case of other important topological parameters of a molecule structure, the determination of a direct linear correlation between the value of lipophilicity and MRL is not possible. However, it does not mean that no relation exists between the chemical structure and MRL values. It is in fact connected with excessively indirect character of the determined MRL value. The detection of possible relationships in an analysis of that type would be facilitated if MRL concentration was a parameter solely associated with the pharmacokinetic properties of a drug. However, many different factors that decide about the safety of a veterinary drug are taken into account in order to determine MRL. Nevertheless, the aim of this study was to show a trend of dependency between the LogP and LogD7.4 of a drug and a lower or higher MRL value as, so far, none of the studies aimed to prove the dependence between lipophilicity and MRL value. A study concerning the influence of chemical structure of veterinary drugs on the MRL value involved similar analyses (11) , but most of the validated models were U shape models. Moreover, no significant influence of parameters that illustrate lipophilicity and solubility in water on a structure of presented arithmetic statements was stated. In that study, the correlation between MRL values determined for muscle tissue and the structure of veterinary drugs was examined. In the case of this correlation, the authors had to create an arithmetic statement consisting of 13 different physicochemical parameters to prove the significance of the model. The difference in relation to the model illustrating the correlation between the chemical structure of drugs and MRL determined for the fatty tissue is considerable. In the case of presented study, a significant correlation with reference to MRL was determined for one physicochemical parameter -LogD7.4. The conclusion for both studies is that in the case of hydrophilic tissues, it is difficult to observe the influence of particular physicochemical parameters on distribution and redistribution processes of the drugs. The kinetics connected with redistribution of drugs has a much more dynamic character in case of hydrophilic tissues than in the case of fatty tissue. It results from both the differences in perfusion and from the chemical composition of the tissue and its physicochemical homogeneousness. The described indirect correlations between MRL determined for the muscles and drug structure require more physicochemical parameters than in the case of MRL determined for fatty tissue. It can also be a result of the processes that hydrophilic and lipophilic drugs undergo after reaching the space, a de facto deep compartment, where their solubility is optimal. In the case of lipophilic drugs, this compartment is genuinely deep, and drugs are eliminated from it with slight dynamics. By contrast, in the case of hydrophilic drugs, the compartment is characterised by high dynamics in terms of redistribution processes and tissue clearance.
The lack of a direct correlation between LogP and MRL does not necessarily mean that the current method of MRL value determination is far from the proposed hypothesis, therefore not allowing to find any common denominator between MRL and LogP or LogD7. 4 (24, 30) . However, that paradox perfectly reflects the character of disposition of extremely lipophilic drugs in an organism. Despite their high lipophilicity, the drugs cannot penetrate numerous membrane systems (1) . High lipophilicity makes them bind to proteins easily. They also show a high affinity to enzymatic proteins. These phenomena frequently contribute to the metabolism of a significant percentage of the administered drug. Moreover, these drugs bind strongly not only to plasma proteins, but also to tissue proteins, and penetrate membranes. All these elements translate into less efficient tissue penetration by drug molecules. These compounds frequently show an affinity for pumping proteins of the P-gp type. The results obtained in this study confirm that increasing lipophilicity does not necessarily favour increased, easy distribution into fat-rich components. This fact is reflected in the current MRL values determined for fatty tissue. This research suggests a new direction for future structure quantitation relationship model based on MRL values analysis. The analysis presented indicates that there are no direct correlations between lipophilicity of the analysed drugs and their MLR value described for fat. However, indirect correlations can be determined after the analyses of fractions. The presented model passes LOO validation, but has no predictive value (does not meet criteria Q 2 asym-Q 2 ). It means that the model cannot be used to determine MRLs of veterinary drugs. The fact that some of MRL values in validation diverge from the rest, result in the lack of model predictive ability. However, the determined correlation is statistically significant and describes a real connection. The presented model indicates that structure MRL indirect relationship could be useful in the case of substances for which MRLs are not determined, or substances used "off label" (extra label) in food producing animals (8) . Currently, animal food production hardly exists without using veterinary drugs and feed additives, which can be used illegally or in improper way (13) . Such a model can help in risk analysis, especially in the case of "off label" drug presence confirmed during routine control in reference laboratory. The created model will facilitate the monitoring of residual level of harmful substances in animal products and the detection of the drugs at the toxicologically unacceptable level.
Summing up, the analysis indicates the existence of an indirect relationship and a particular trend between the LogP, LogD7.4, and the MRL values determined for fatty tissue. This relationship, determined for individual fractions of compounds, confirms that with the increasing LogP or LogD7.4 value, the MRL value increases as well. This correlation seemingly contradicts the theory that claims that strongly lipophilic drugs are more easily distributed in fatty tissue.
